| Market Cap | €3.35B | |
| Enterprise Value | €6.79B | |
| Revenue | €20.90B | −2.7% |
| Gross Profit | €4.23B | +3.6% |
| EBITDA | — | — |
| Net Income | €200.0M | +23.5% |
| Diluted EPS | €0.81 | +22.7% |
| Free Cash Flow | €1.50B | −3.2% |
| DPS (FY2025) | — |
| Trailing yield | — |
| Payout ratio | 71.5% |
| Growth streak | — |
| 5y DPS growth | — |
| Fiscal year | DPS | YoY | Basis |
|---|---|---|---|
| FY20252025-12-31 | — | — | reported |
| FY20242024-12-31 | — | — | reported |
| FY20232023-12-31 | — | — | reported |
| FY20222022-12-31 | — | — | reported |
| Ratio | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend · 7y | vs own |
|---|---|---|---|---|---|---|---|---|---|
| ▾Margins | |||||||||
| Gross Margin | — | 13.11% | 17.61% | 17.20% | 17.92% | 18.99% | 20.23% | 92% | |
| Operating Margin | — | −5.21% | 2.35% | 3.21% | 3.38% | — | — | — | |
| NOPAT Margin | — | −4.12% | 1.30% | 1.86% | 2.23% | — | — | — | |
| Net Margin | — | −6.63% | 1.01% | 1.15% | 1.00% | 0.75% | 0.96% | 42% | |
| FCF Margin | — | 5.95% | 5.09% | 5.49% | 6.80% | 7.21% | 7.17% | 75% | |
| FCFE Margin | — | 13.49% | 2.03% | 11.19% | 4.68% | 6.62% | 3.43% | 25% | |
| OCF Margin | — | 11.19% | 9.43% | 9.52% | 11.17% | 12.50% | 10.95% | 42% | |
| Gross Profitability | — | 11.43% | 16.14% | 15.65% | 18.16% | 18.84% | 20.86% | 92% | |
| Capex Intensity | — | 5.24% | 4.34% | 4.03% | 4.37% | 5.29% | 3.78% | 8% | |
| ▸Returns on Capital · 6 ratios | |||||||||
| ▸DuPont factors (ROE drivers) · 4 ratios | |||||||||
| ▸Earnings quality · 5 ratios | |||||||||
| ▸Liquidity & coverage · 6 ratios | |||||||||
| ▸Leverage · 5 ratios | |||||||||
| ▸Working capital · 8 ratios | |||||||||
| ▸Capital allocation · 5 ratios | |||||||||
| ▸Per share · 3 ratios | |||||||||
| ▸Other · 1 ratios | |||||||||
The five drivers multiply to 6.1% vs reported ROE 6.0%. High ROE from margin and turnover is earned; from the equity multiplier it is borrowed.
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | €16.44B | €17.26B | €20.04B | €22.04B | €21.49B | €20.90B |
| YoY % | +5.0% | +16.1% | +10.0% | -2.5% | -2.7% | |
| Cost of Revenue | €14.28B | €14.22B | €16.59B | €18.09B | €17.41B | €16.67B |
| YoY % | -0.4% | +16.7% | +9.1% | -3.8% | -4.2% | |
| R&D Expense | €1.70B | €1.51B | €1.88B | €2.03B | €2.13B | €2.27B |
| YoY % | -10.9% | +24.5% | +7.9% | +4.8% | +6.9% | |
| Selling & Marketing Expense | €259.0M | €259.0M | €286.0M | €324.0M | €296.0M | €275.0M |
| YoY % | 0.0% | +10.4% | +13.3% | -8.6% | -7.1% | |
| SG&A Expense | €573.0M | €572.0M | €646.0M | €760.0M | €739.0M | €704.0M |
| YoY % | -0.2% | +12.9% | +17.6% | -2.8% | -4.7% | |
| Operating Income | -€857.0M | €406.0M | €644.0M | €744.0M | — | — |
| YoY % | +58.6% | +15.5% | ||||
| Equity Method Income | -€278.0M | -€243.0M | €115.0M | €17.0M | €12.0M | -€20.0M |
| YoY % | -85.2% | -29.4% | ||||
| Pretax Income | -€938.0M | €442.0M | €509.0M | €454.0M | €333.0M | €460.0M |
| YoY % | +15.2% | -10.8% | -26.7% | +38.1% | ||
| Income Tax | €132.0M | €197.0M | €214.0M | €154.0M | €99.0M | €205.0M |
| YoY % | +49.2% | +8.6% | -28.0% | -35.7% | +107.1% | |
| Net Income (incl. NCI) | -€1.07B | €245.0M | €295.0M | €300.0M | €234.0M | €255.0M |
| YoY % | +20.4% | +1.7% | -22.0% | +9.0% | ||
| Minority Interest (P&L) | €19.0M | €70.0M | €65.0M | €79.0M | €72.0M | €55.0M |
| YoY % | +268.4% | -7.1% | +21.5% | -8.9% | -23.6% | |
| Net Income | -€1.09B | €175.0M | €230.0M | €221.0M | €162.0M | €200.0M |
| YoY % | +31.4% | -3.9% | -26.7% | +23.5% | ||
| EPS (Basic) | -€4.55 | €0.73 | €0.95 | €0.91 | €0.67 | €0.82 |
| YoY % | +30.1% | -4.2% | -26.4% | +22.4% | ||
| EPS (Diluted) | -€4.55 | €0.72 | €0.94 | €0.90 | €0.66 | €0.81 |
| YoY % | +30.6% | -4.3% | -26.7% | +22.7% | ||
| Dividends Declared per Share | €0 | €0 | — | — | — | — |
| YoY % | +50.0% |
Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
| FY20212021-12-31 | €0.30 | +50.0% | reported |
| FY20202020-12-31 | €0.20 | — | reported |
